Baxter International Inc (BAX)
33.21
+0.22
(+0.67%)
USD |
NYSE |
Nov 22, 16:00
33.12
-0.09
(-0.27%)
Pre-Market: 20:00
Baxter International Free Cash Flow: 391.00M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2024 | 391.00M |
June 30, 2024 | 514.00M |
March 31, 2024 | 704.00M |
December 31, 2023 | 1.034B |
September 30, 2023 | 1.108B |
June 30, 2023 | 885.00M |
March 31, 2023 | 834.00M |
December 31, 2022 | 591.00M |
September 30, 2022 | 844.00M |
June 30, 2022 | 1.211B |
March 31, 2022 | 1.393B |
December 31, 2021 | 1.531B |
September 30, 2021 | 1.496B |
June 30, 2021 | 1.354B |
March 31, 2021 | 1.265B |
December 31, 2020 | 1.159B |
September 30, 2020 | 1.322B |
June 30, 2020 | 1.502B |
March 31, 2020 | 1.573B |
December 31, 2019 | 1.408B |
September 30, 2019 | 1.273B |
June 30, 2019 | 1.053B |
March 31, 2019 | 1.001B |
December 31, 2018 | 1.358B |
September 30, 2018 | 1.04B |
Date | Value |
---|---|
June 30, 2018 | 1.20B |
March 31, 2018 | 1.324B |
December 31, 2017 | 1.098B |
September 30, 2017 | 1.426B |
June 30, 2017 | 1.317B |
March 31, 2017 | 1.518B |
December 31, 2016 | 935.00M |
September 30, 2016 | 893.00M |
June 30, 2016 | 549.00M |
March 31, 2016 | 461.00M |
December 31, 2015 | 860.00M |
September 30, 2015 | 1.231B |
June 30, 2015 | 2.344B |
March 31, 2015 | 2.034B |
December 31, 2014 | 2.29B |
September 30, 2014 | 2.862B |
June 30, 2014 | 2.296B |
March 31, 2014 | 2.536B |
December 31, 2013 | 2.492B |
September 30, 2013 | 1.624B |
June 30, 2013 | 1.544B |
March 31, 2013 | 1.832B |
December 31, 2012 | 1.945B |
September 30, 2012 | 1.974B |
June 30, 2012 | 2.173B |
Free Cash Flow Range, Past 5 Years
391.00M
Minimum
Sep 2024
1.573B
Maximum
Mar 2020
1.106B
Average
1.185B
Median
Free Cash Flow Benchmarks
Boston Scientific Corp | 1.892B |
Haemonetics Corp | 20.35M |
Accuray Inc | -14.24M |
Masimo Corp | 149.60M |
Insulet Corp | 218.20M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 253.00M |
Cash from Investing (Quarterly) | -164.00M |
Cash from Financing (Quarterly) | -146.00M |
Free Cash Flow Per Share (Quarterly) | 0.4473 |
Free Cash Flow to Equity (Quarterly) | 198.00M |
Free Cash Flow to Firm (Quarterly) | 305.91M |
Free Cash Flow Yield | 2.31% |